Eligi
Med
Ensayos clínicos
Suscripción
Sobre EligiMed
Ensayos Clínicos de Gastroenterología | EligiMed
Ensayos clínicos
8.676 ensayos encontrados
Terminado
Fase 3
ClinicalTrials.gov
Safety and Antiviral Activity of TPV in Hepatitis C or Hepatitis B HIV Coinfected Patients - TDM Randomised Pilot Evaluation
INTERVENTIONAL
Inicio: 1 de mar de 2007
ID: NCT00447902
Completado
Fase 4
ClinicalTrials.gov
Phase 4: Study of Ketamine Inhibition of Interleukin 6 in Hepatic Resections Requiring Temporary Porto-arterial Occlusion
INTERVENTIONAL
Inicio: 1 de jun de 2001
ID: NCT00978757
Completado
Fase 2
ClinicalTrials.gov
A Phase II Randomized, Double-blind, Placebo-controlled, Proof-of-Concept Study to Evaluate the Safety and Efficacy of Cotadutide in Participants With Non-cirrhotic Non-alcoholic Steatohepatitis With Fibrosis
INTERVENTIONAL
Inicio: 14 de jul de 2022
ID: NCT05364931
Terminado
Fase 3
ClinicalTrials.gov
A 46-week, Double-blind, Placebo-controlled, Phase 3 Study With a 6-week Randomized-withdrawal Period to Evaluate the Safety and Efficacy of Relamorelin in Patients With Diabetic Gastroparesis
INTERVENTIONAL
Inicio: 24 de ene de 2018
ID: NCT03420781
Completado
Fase 4
ClinicalTrials.gov
A Randomized, Double-blind, Parallel-group, 26-week Study Comparing the Efficacy and Safety of Indacaterol (Onbrez® Breezhaler® 150 mcg o.d.) With Salmeterol/Fluticasone Propionate (Seretide® Accuhaler® 50 mcg/500 mcg b.i.d.) in Patients With Moderate Chronic Obstructive Pulmonary Disease
INTERVENTIONAL
Inicio: 1 de feb de 2012
ID: NCT01555138
Terminado
Fase 3
ClinicalTrials.gov
A Seamless, Adaptive, Phase 2b/3, Double-Blind, Randomized, Placebo-controlled, Multicenter, International Study Evaluating the Efficacy and Safety of Belapectin (GR MD-02) for the Prevention of Esophageal Varices in NASH Cirrhosis
INTERVENTIONAL
Inicio: 25 de jun de 2020
ID: NCT04365868
Activo, no recluta
Fase 3
ClinicalTrials.gov
A Phase 3 Randomized, Open-Label, Multicenter Clinical Study of CGT9486+Sunitinib vs. Sunitinib in Subjects With Locally Advanced, Unresectable, or Metastatic Gastrointestinal Stromal Tumors
INTERVENTIONAL
Inicio: 14 de abr de 2022
ID: NCT05208047
Completado
Fase 3
ClinicalTrials.gov
A Randomized, Double Blind, Placebo Controlled, Multicenter Phase III Study of Regorafenib in Patients With Hepatocellular Carcinoma (HCC) After Sorafenib
INTERVENTIONAL
Inicio: 14 de may de 2013
ID: NCT01774344
Completado
ClinicalTrials.gov
Long-term Safety Follow-up of REMICADE (RESULTS)
OBSERVATIONAL
Inicio: 1 de feb de 2002
ID: NCT00261976
Completado
Fase 4
ClinicalTrials.gov
A 26-week, Randomized, Double Blind, Parallel-group Multicenter Study to Assess the Efficacy and Safety of QVA149 (110/50 μg o.d.) vs Tiotropium (18 µg o.d.) + Salmeterol/Fluticasone Propionate FDC (50/500 µg b.i.d.) in Patients With Moderate to Severe COPD
INTERVENTIONAL
Inicio: 20 de nov de 2015
ID: NCT02603393
Completado
Fase 3
ClinicalTrials.gov
A Phase 3, Open Label Study of Safety and Efficacy With BMS-790052 Plus Peg-Interferon Alfa 2a and Ribavirin in Previously Untreated HCV Patients Coinfected With Human Immunodeficiency Virus (HIV) and Hepatitis C Virus (HCV)
INTERVENTIONAL
Inicio: 1 de dic de 2011
ID: NCT01471574
Terminado
Fase 3
ClinicalTrials.gov
A Multi-Center, Randomized, Double-Blind, Active-Control, 96 Week, Phase III Trial of the Efficacy and Safety of Clevudine Compared With Adefovir at Weeks 48 and 96 in Nucleoside Treatment-Naïve Patients With HBeAg Negative Chronic Hepatitis Due to Hepatitis B Virus
INTERVENTIONAL
Inicio: 1 de ago de 2007
ID: NCT00496158
Completado
ClinicalTrials.gov
Prospective Collection of Data in Pts With Peripheral T-Cell Lymphoma: PTCL,NOS;AITL; Extranodal NK/T-cell;Enteropathy-type; Hepatosplenic γ-δ; Subcutaneous Panniculitis-like; ALCL,Primary Systemic Type. By the Intl. T-Cell Lymphoma Project
OBSERVATIONAL
Inicio: 1 de sept de 2006
ID: NCT01142674
Completado
Fase 3
ClinicalTrials.gov
A Randomized, Double-blind, Placebo-controlled, Multicenter Phase III Study to Evaluate the Efficacy and Safety of ABX464 Once Daily for Induction Treatment in Subjects With Moderately to Severely Active Ulcerative Colitis
INTERVENTIONAL
Inicio: 21 de dic de 2022
ID: NCT05507216
Terminado
Fase 2
ClinicalTrials.gov
A Randomized, Controlled, Open Label, Two Arms, Exploratory Study to Evaluate the Effect of Everolimus on Histologically Assessed Fibrosis Progression (Ishak-Knodell) in Liver Transplant Recipients With Recurrent Hepatitis C Viral Infection as Compared to Standard Treatment.
INTERVENTIONAL
Inicio: 1 de dic de 2007
ID: NCT00582738
Completado
ClinicalTrials.gov
Real-world Data of Moderate to Severe Inflammatory Bowel Disease in Argentina: A Non-interventional, Multicenter Study to Evaluate Disease Control, Treatment Patterns, Burden of Disease and Quality of Life
OBSERVATIONAL
Inicio: 12 de dic de 2018
ID: NCT03488030
Terminado
Fase 3
ClinicalTrials.gov
A Multi-Center, Randomized, Double-Blind, Active-Control, 96 Week, Phase III Trial of the Efficacy and Safety of Clevudine Compared With Adefovir at Weeks 48 and 96 in Nucleoside Treatment-Naïve Patients With HBeAg Positive Chronic Hepatitis Due to Hepatitis B Virus
INTERVENTIONAL
Inicio: 1 de ago de 2007
ID: NCT00496002
Activo, no recluta
Fase 3
ClinicalTrials.gov
Phase 3 Multicenter, Randomized, Double-Blind, Study to Assess the Efficacy and Safety of Treatment With Bepirovirsen in Nucleos(t)Ide Analogue-treated Participants With Chronic Hepatitis B Virus (B-Well 1)
INTERVENTIONAL
Inicio: 7 de dic de 2022
ID: NCT05630807
Completado
Fase 2
ClinicalTrials.gov
A Phase 2, Open-Label Study of Daclatasvir (BMS-790052) and TMC435 in Combination With or Without Ribavirin (RBV) For Treatment-Naive Subjects or Null Responders to Prior Peginterferon Alfa (PegIFN)/RBV Therapy With Genotype 1 Chronic Hepatitis C
INTERVENTIONAL
Inicio: 1 de jul de 2012
ID: NCT01628692
Completado
Fase 1
ClinicalTrials.gov
A Phase 1 Study of BMS-986416 Alone and in Combination With Nivolumab in Select Solid Tumors
INTERVENTIONAL
Inicio: 9 de ago de 2021
ID: NCT04943900
Anterior
1
...
29
30
31
...
434
Siguiente
Filtros